MML Investors Services’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,402
Closed -$226K 2692
2024
Q4
$226K Sell
7,402
-627
-8% -$20.2K ﹤0.01% 2441
2024
Q3
$225K Sell
8,029
-1,392
-15% -$34.3K ﹤0.01% 2357
2024
Q2
$215K Buy
9,421
+1,045
+12% +$24.1K ﹤0.01% 2305
2024
Q1
$255K Sell
8,376
-179
-2% -$6K ﹤0.01% 2214
2023
Q4
$305K Buy
8,555
+2,770
+48% +$103K ﹤0.01% 2032
2023
Q3
$253K Sell
5,785
-352
-6% -$17.2K ﹤0.01% 2031
2023
Q2
$303K Buy
6,137
+921
+18% +$42.4K ﹤0.01% 1935
2023
Q1
$216K Buy
5,216
+497
+11% +$20.6K ﹤0.01% 1870
2022
Q4
$209K Buy
+4,719
New +$197K ﹤0.01% 2001
2021
Q3
Sell
-2,794
Closed -$222K 1948
2021
Q2
$222K Buy
+2,794
New +$203K ﹤0.01% 1774

Other funds holding ATRC

MML Investors Services's ATRC Position: Q1 2025 in Review

MML Investors Services sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 7,402 shares — an estimated $226K sold.

MML Investors Services first reported a position in ATRC in Q2 2021 and held it in 10 quarters. The position peaked at $305K in Q4 2023. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

  • MML Investors Services reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
  • MML Investors Services sold 7,402 AtriCure shares in Q1 2025, an estimated $226K.
  • MML Investors Services first reported a position in AtriCure in Q2 2021 and held it in 10 quarters.
  • MML Investors Services's AtriCure position peaked at $305K in Q4 2023.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on MML Investors Services's 13F filing for Q1 2025, filed 14 May 2025.